Stimulation of Muscle Protein Degradation and Prostaglandin E2 Release by Leukocytic Pyrogen (Interleukin-1): A Mechanism for the Increased Degradation of Muscle Proteins during Fever

New England Journal of Medicine

Volumn 308, Issue 10, 1983, Pages 553-558

  Baracos, Vickie ^a   Rodemann, H Peter ^a   Dinarello, Charles A ^a   Goldberg, Alfred L ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOXISTATIN ACID; INDOMETACIN; INSULIN; INTERLEUKIN 1; PROSTAGLANDIN F2; PROTEINASE INHIBITOR; RADIOISOTOPE;

ANIMAL MODEL; DRUG EFFICACY; FEVER; MUSCLE; NONHUMAN; PHENYLALANINE C 14; PROTEIN DEGRADATION; SEPSIS;

ANIMAL; BODY TEMPERATURE; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; FEVER; HUMAN; IN VITRO; INDOMETHACIN; LEUKOCYTES; LYSOSOMES; MUSCLE PROTEINS; MUSCLES; PEPTIDE HYDROLASES; PROSTAGLANDINS E; PROTEINS; PYROGENS; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0020678196     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198303103081002     Document Type: Article

References (44)

1. Dinarello CA, Wolff SM. Molecular basis of fever in humans. Am J Med. 1982; 72: 799–819.
2. Bernheim HA, Block LH, Atkins E. Fever: pathogenesis, pathophysiology, and purpose. An Intern Med. 1979; 91: 261–70.
3. Kluger MJ. Fever, its biology, evolution, and function. Princeton, N.J.: Princeton University Press, 1979
4. Rosenwasser LJ, Dinarello CA. Ability of human leukocytic pyrogen to enhance phytohaemagglutinin induced murine thymocyte proliferation. Cell Immunol. 1981; 63: 134–42.
5. Murphy PA, Simon PL, Willoughby WF. Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages. J Immunol. 1980; 124: 2498–501.
6. Atkins E, Huang WC. Studies on the pathogenesis of fever with influenza viruses. I. The appearance of an endogenous pyrogen in the blood following intravenous injection of virus. J Exp Med. 1958; 107: 383–402.
7. Atkins E, Wood WB Jr. Studies on the pathogenesis of fever. II. Identification of an endogenous pyrogen in the blood stream following the injection of typhoid vaccine. J Exp Med. 1955; 102: 499–516.
8. Dinarello CA, Renfer L, Wolff SM. The production of antibody against human leukocytic pyrogen. J Clin Invest. 1977; 60: 465–72.
9. Murphy PA, Cebula TA, Levin J, Windle BE. Rabbit macrophages secrete two biochemically and immunologically distinct endogenous pyrogens. Infect Immun. 1981; 34: 177–83.
10. Bermheim HA, Gilbert TM, Stitt JT. Prostaglandin E levels in the third ventricular cerebrospinal fluid of rabbits during fever and changes in body temperature. J Physiol (Lond). 1980; 301: 69–78.
11. Dinarello CA, Bernheim HA. Ability of human leukocytic pyrogen to stimulate brain prostaglandin synthesis in vitro. J Neurochem. 1981; 37: 702–8.
12. Veale WL, Cooper KE. Comparison of sites of action of PGE and leukocyte pyrogen in brain. In: Lomax P. Schoernbaum E, eds. Proceedings of the Symposium on Temperature Regulation and Drug Act, Paris, 1974. Basel: S Karger, 1975:218–26.
13. Milton AS, Wendlandt S. Effects on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of unanesthetized cats and rabbits. J Physiol (Lond). 1971; 218: 325–36.
14. McAdam KPWJ, Dinarcllo CA. Induction of scrum amyloid A synthesis by human leukocytic pyrogen. In: Agarwal MK, ed. Bacterial endotoxins and host response. Amsterdam: Elscvier/North-Holland, 1980:167–78.
15. Sztein MB, Vogel SN, Sipe JD, et al. The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen. Cell Immunol. 1981; 63: 164–76.
16. Beer DJ, Dinarcllo CA, Roscnwasscr LJ, Rocklin RE. Human leukocytic pyrogen subserves an accessory function in the generation ofhistamine- and concanavalin A-induccd suppressor T-cclls. J Clin Invest. 1982; 70: 392–400.
17. Beisel WR. Metabolic response to infection. Annu Rev Med. 1975; 26: 9–20.
18. Clowes GHA Jr, Randall HT, Cha C-J. Amino acid and energy metabolism in septic and traumatized patients. JPEN. 1980; 4: 195–205.
19. Wilmore DW, Black PR, Muhlbachcr F. Injured man: trauma and sepsis. In: Winters RW, ed. nutritional management of the seriously ill patient: Bristol Meyers Symposium on Nutrition, November, 1981. New York: Academic Press, (in press).
20. Kiclmann AA. Weight fluctuations after immunization in a rural preschool child community. Am J Clin Nutr. 1977; 30: 592–8.
21. Long CL, Birkhahn RH, Geiger JW, Betts JE, Schiller WR, Blakemore WS. Urinary excretion of 3-melhylhislidine: an assessment of muscle protein catabolism in adult normal subjects and during malnutrition, sepsis, and skeletal trauma. Metabolism. 1981; 30: 765–76.
22. Garlick PJ, McNurlan MA, Fern EB, Tomkins AM, Waterlow JC. Stimulation of protein synthesis and breakdown by vaccination. Br Med J. 1980; 281: 263–5.
23. Goldberg AL, Baracos VE, Rodemann HP, Dinarello CA, Waxman L. Muscle protein turnover in pathological states: involvement of prostaglandins, calcium, and leukocytic pyrogen. Fed Proc. (in press).
24. Rodemann HP, Goldberg AL. Arachidonic acid, prostaglandin E2 and F2α influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem. 1982; 257: 1632–8.
25. Everett AW, Zak R. Problems and interpretations of techniques used in studies of protein turnover. In: Wildenthal K, ed. Degradative processes in heart and skeletal muscle. Amsterdam: Elsevier/North-Holland, 1980:31–47. (Research monographs in cell and tissue physiology. Vol. 3).
26. Libby P, Goldberg AL. The control and mechanism of protein breakdown in striated muscle: studies with selective inhibitors. In: Wildenthal K, ed. Degradative processes in heart and skeletal muscle. Amsterdam: Elsevier/ North-Holland, 1980:201–22. (Research monographs in cell and tissue physiology. Vol. 3).
27. Goldberg AL, Tischler M, DeMartino G, Griffin G. Honmonal regulation of protein degradation and synthesis in skeletal muscle. Fed Proc. 1980; 39: 31–6.
28. Dinarello CA, Bendtzen K, Wolff SM. Studies on the active site of human leukocytic pyrogen. Inflammation. 1982; 6: 63–78.
29. Dinarello CA, Renfer L. Wolff SM. Human leukocytic pyrogen: purification and development of a radioimmunoassay. Proc Natl Acad Sci USA. 1977; 74: 4624–7.
30. Goldberg AL, Swamy KHS, Chung CH, Larimore FS. Proteases in Escherichia coli. Methods Enzymol. 1981; 80: 680–702.
31. Goldberg AL, Martel SM, Kushmerick NJ. In vitro preparations of the diaphragm and other skeletal muscles. Methods Enzymol. 1975; 39: 82–94.
32. Fulks RH, Li JB, Goldberg AL. Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J Biol Chem. 1975; 250: 290–8.
33. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature [New Biol]. 1971; 231: 232–5.
34. Hanada K, Tamai M. Yamaguchi M, Ohmura S, Sawada J, Tanaka I. Isolation and characterization of E-64, a new thiol protease inhibitor. Agric Biol Chem. 1978; 42: 523–8.
35. Tischler ME, Desautels M, Goldberg AL. Does leucine, leucyl-tRNA or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J Biol Chem. 1981; 257: 1613–21.
36. Rodemann HP, Waxman L, Goldberg AL. The stimulation of protein degradation by Ca2+ is mediated by PGE2 and does not require the calcium-activated protease. J Biol Chem. 1982; 257: 8716–23.
37. Clowes GHA Jr, George B, Ryan NT. Induction of accelerated proteolysis and amino acid release from skeletal muscle by a potent nonprotein factor in the plasma of septic patients. In: McConn R, ed. The role of chemical mediators in the pathophysiology of acute illness and injury. New York: Raven Press, 1982:327–41.
38. Clowes GHA, George BC, Villee CA Jr, Saravis CA. Muscle proteolysis induced by a circulating peptide in septic and traumatized patients. N Engl J Med. 1983; 308: 545–52.
39. Gordon AH, Parker ID. A pyrogen derived from human white cells which is active in mice. Br J Exp Pathol. 1980; 61: 534–9.
40. Kluger MJ, Ringler DH, Anver MR. Fever and survival. Science. 1975; 188: 166–8.
41. Goldberg AL, Chang TW. Regulation and significance of amino acid metabolism in skeletal muscle. Fed Proc. 1978; 37: 2301–7.
42. Ruderman NB. Muscle amino acid metabolism and gluconeogenesis. Annu Rev Med. 1975; 26: 245–58.
43. Kampschmidt RF, Pulliam LA, Upchurch HF. The activity of partially purified leukocytic endogenous mediator in endoloxin-resistant C3H/HeJ mice. J Lab Clin Med. 1980; 95: 616–23.
44. Ferreira SH, Vane JR. Mode of action of anti-inflammatory agents which are prostaglandin synthetase inhibitors. In: Vane JR, Ferreira SH, eds. Anti-inflammatory drugs. Berlin: Springer-Verlag, 1979:348–98. (Handbook of experimental pharmacology. Vol. 50. Part 2).